pneumophila, supporting its role in the modulation of the antimicrobial activity. Finally, U937 cells transfected with the NAP-2 construct showed an adherence that was dramatically enhanced when the substrate was fibronectin. We conclude that human phagocytes produce CXCL7 variants that may have a significant influence on the immune response against bacterial pathogens.
Introduction
Mycobacterium tuberculosis and Legionella pneumophila are both bacteria implicated in pulmonary diseases. An average of 356 cases of legionellosis per year reported in the United States is only a fraction of the 8,000 to 18,000 cases which are estimated to occur annually. The epidemiology of Legionnaires' disease is usually related to community outbreaks, frequently linked to cooling waters and whirlpool spas (Fields et al., 2002) . As regards tuberculosis, it remains a first order health problem. Cytokines are critical modulators of the immune response. Among them, the chemokines constitute a group of small chemotactic cytokines divided into four families (CXC, CC, C and CX3C) on the basis of the pattern of cysteine residues in the ligands (Zlotnik and Yoshie, 2000) . The role of chemokines in both tuberculosis and legionellosis is poorly characterized. L. pneumophila induces the production of IL-8 (CXCL8) in human lung epithelial cells (Teruya et al., 2007 ), but we are not aware of any studies on chemokine induction by this bacterium in human macrophages. On the other hand, M. tuberculosis induces CXCL chemokines in human macrophages, including CXCL2, CXCL5 and CXCL8 (Volpe et al., 2006) . Furthermore, virulent strains induce CCL2, CCL3, CCL4 and CCL5 expression, a response that is attenuated in avirulent strains (Saukkonen et al., 2002) . CXCL7 is the most abundant chemokine in platelets, where it is stored in their α-granule compartment, and may occur within a range from 1.6 to 4.8 µM in normal serum. There are several variants proteolytically derived from the precursor molecule pro-platelet basic protein (PPBP, 128 aa). Amino-terminal truncations include platelet basic protein (PBP, 94 aa), connective tissue-activating peptide-III (CTAP-III, 85 aa), β-thromboglobulin (β-TG, 81 aa) and neutrophil activating protein 2 (NAP-2, 70 aa). In addition, the CTAP-III and the NAP-2 variants may also have carboxi-terminal truncations of either 4 or 7 aa. CXCL7 has a tripeptide motif (ELR) which is required for binding to and cell activation through the CXCR-1 and CXCR-2 receptors . Besides platelets, CXCL7 is also known to be expressed in T cells (Skerka et al., 1993) and monocytes (El-Gedaily et al., 2004) . With the exception of PF-4 (CXCL4) , all ELR+ CXC chemokines attract neutrophils, but in the case of CXCL7 only the NAP-2 variant exhibits this activity and although NAP-1 (CXCL8) shows only one chemotactic peak at nM concentrations, NAP-2 has two peaks at 4nM and 3 µM, respectively (Ludwig et al., 1997) . Both NAP-2 and NAP-1 bind the same receptors and attract the same cells, but it seems that NAP-2, rather than NAP-1, is the chemokine that chemoattracts neutrophils about monocytes (Malawista et al., 2002) . Several other biological activities have been studied in CXCL7 variants, including enzyme release in human neutrophils (Brandt et al., 1991) . NAP-2 does not promote a respiratory burst in monocytes, and only a small activity is observed in neutrophils, ten times lower than that of NAP-1 . It is particularly interesting the microbicidal activity that chemokines like the CXCL7 variants PBP and CTAP-III exert, with mechanisms of action similar to defensins (Tang et al., 2002) . In a recent report Khajoee et al. describe the differential gene expression of CXCL7 in GMmacrophages (granulocyte-macrophage colony-stimulating factor-induced human monocyte derived macrophages) and M-macrophages (macrophage colony-stimulating factor-induced human monocyte derived macrophages) infected with M. bovis bacillus Calmette-Guérin (BCG). Furthermore, they found that CXCL7 might have a role in the resistance against mycobacteria and in the production of reactive oxygen intermediates (Khajoee et al., 2006) .
The immunologic response of monocytes to M. tuberculosis and L.
pneumophila is very different when they are activated with IFNγ. While L. pneumophila is readily inhibited (Bhardwaj et al., 1986) , M. tuberculosis survives the antimicrobial activity of the phagocyte (Douvas et al., 1985) . In order to investigate the differences in the gene expression of infected monocyte derived macrophages (MDM), we have constructed a new subtraction library of cDNA from human IFNγ activated MDM infected with either M. tuberculosis or L. pneumophila. This library has been partially characterized, and a clone representing CXCL7 was scored as positive for differential expression in these macrophages. Subsequently, we performed a series of experiments to analyze the role of CXCL7 in infection. We describe for the first time that polymorphonulear neutrophils (PMN) produce CXCL7, and that this protein enhances the antimicrobial activity induced by IFNγ in MDM against L. pneumophila. Although it had already been reported that NAP-2 induces cellular adhesion through CD11b/CD18, we characterize fibronectin as a new adhesion substrate specifically recognized after NAP-2 induction.
Materials and methods

Bacterial strains
M. tuberculosis HL186T was isolated at the Hospital de León (Microbiology Service) and kindly provided by Julio Blanco and Manuela Caño. It was grown on 7H11 agar supplemented with 0.2% glycerol and 10% Middlebrook enrichment OADC (Oleic acid, albumin, dextrose, catalase; Becton Dickinson Microbiology Systems, San Agustín de Guadalix, Madrid, Spain). L. pneumophila Philadelphia, ATCC 13151, generously provided by Carmen Pelaz, was grown on BCYE (buffered charcoal yeast extract) agar plates. Bacteria from fresh culture in agar plates were suspended in RPMI medium without serum. To obtain isolated mycobacteria, they were sonicated using an S-450 digital ultrasonic cell disruptor (Branson Ultrasonics, Danbury, CT, USA). Pulses of 10 s were applied with a microtip at an amplitude of 10% (2 W), and sonicated bacteria were centrifuged at 100 × g for 1 min at room temperature. After recovering the supernatants, sonications were repeated until individualized bacteria were obtained, usually three or four rounds. At the end most bacteria were alive and very few groups remained, with ≤ 5 bacteria per group, as determined by the LIVE/DEAD Baclight bacterial kit (Molecular Probes, Invitrogen, Prat de Llobregat, Barcelona, Spain). This treatment was not necessary for L. pneumophila. After addition of glycerol to 20%, single use aliquots were frozen at -80ºC. 
MDM, PMN and cell lines
Plasmids and transfection
For K562 transient transfection, CXCL7 was cloned by PCR using the following primers: (F) ATCAAAGCTTATGAGCCTCAGACTTG and (R)
ATCACTCGAGTTAATCAGCAGAT, which include the Hind III and Xho I restriction sites, respectively. This PCR product was subcloned in pcDNA3 (Invitrogen) and is translated into a 128 aa product that includes the leader sequence (aa 1 to 34). 2×10 6 K562 cells in RPMI without serum were transiently electroporated with 10 µg of pcDNA3-CXCL7 at 260 v, 1 mF, using a Gene-Pulser II (Bio-Rad). Cells were grown in RPMI/10% FBS (3 ml) for two days in 6 wells plates.
For U937 cells stable transfection we constructed a NAP-2 form obtained by deleting the sequence that codify aa 35 to 59 by a two-step PCR that keeps the leader sequence. Using as template the complete CXCL7 sequence, the deletion was obtained with the following primers: (F) GCTCTGGCTTCTGAACTCCG and (R)
CGGAGTTCAGAAGCCAGAGC. The recombinant plasmid was tested by sequencing.
U937 cells were transfected as described above, and cells were selected with 200 µg/ml G418 (Gibco, Invitrogen) for two months.
Quantitative polymerase chain reaction ( /(E CXCL7 ) Ct CXCL7 , where E is the efficiency of the reaction (1.93 for EF1α and 2.01 for CXCL7). The primers used for EF-1α and CXCL7 were:
(R) TCTGGGAGCATCTGGGTCC.
CXCL7 and CXCL8 quantification
Supernatants were obtained from cells cultured as indicated for qPCR. To remove bacteria, samples were centrifuged 3 min at 8000 × g at room temperature in ultrafree-MC filter units of 0.45 µm (Millipore Ibérica, Madrid, Spain) and frozen at -80ºC. Chemokines were quantified by the human CXCL7/NAP-2 and human CXCL8/IL-8 DuoSet ELISA development system (R&D Systems, Minneapolis, MN, USA).
Western blot analysis
CXCL7 was immunoprecipitated with GammaBind G Sepharose (GE Healthcare), with 2 µg of a monoclonal anti-human NAP-2 antibody (R&D Systems).
Samples were used for sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) on 16% Tris/Tricine mini-gels under denaturing conditions (6 M urea) (Schägger, 2006) . Before electrophoresis, samples were diluted in sample buffer and incubated for 10 min at 95ºC. To keep the proteins in a reduced form, 4% ( 
Antimicrobial activity assays
Experiments were made in 96-well plates, always in a total volume of 100 µl. (Fazal et al., 1992 ).
pcDNA3-NAP-2 stable transfected U937 cells were cultured in G418 free medium for four days and differentiated overnight with 50 nM phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich). Infection, cell lysis and colony counting were performed as described.
Cell adhesion assay 50 µl of human fibronectin, mouse collagen, type IV or mouse laminin (100 µg/ml, Becton Dickinson) were added to corresponding wells well (96 well plates) and incubated overnight. After three washes with PBS, 2×10 4 U937 cells were inoculated to either coated or uncoated wells, and incubated for 90 min at 37ºC. In inhibition experiments 1 mg/ml of the peptide with the sequence GRGDSP (Calbiochem, Merck Chemicals, Nottingham, UK) was added to the cells 30 min before inoculating the plates. Non-adherent cells were removed by three washes with PBS. Remaining cells were counted by cell lysis and naphtol blue black staining of nuclei (Nakagawara and Nathan, 1983) . Briefly, 50 µl of lysis buffer (1% Triton X-100, 0.05% naphtol blue black, 0.1 M citric acid, pH 2.2, all reagents from Sigma-Aldrich) were added for 5 min at room temperature. Stained nuclei were counted in a Neubauer chamber under an inverted microscope.
Statistical analysis
Data followed a normal distribution (Shapiro-Wilk test), with homogeneous variance (Levene test) and were expressed as means with standard deviation (SD).
Comparisons of two groups were performed by Student's t-test, and more than two groups by one-way ANOVA. Pairwise comparisons were performed by the HSD Tukey's procedure. When variance was not homogeneous, comparisons were performed by the Dunnett's T3 procedure. A p value <0.05 was considered significant. Data was analysed with PASW Statistics 18 (SPSS Ibérica, Madrid, Spain).
Results
CXCL7 expression in infected human MDM
To characterize differences in MDM gene expression we constructed a cDNA subtracted library from IFNγ activated MDM infected with either M. tuberculosis or L.
pneumophila. One of the positive clones of this partially characterized library corresponded to CXCL7, which was isolated from the M. tuberculosis subtracted pool.
To confirm this finding we analyzed cDNA from an independent sample of MDM from healthy volunteers activated with IFNγ and infected with either bacterium. Indeed, we appreciated that CXCL7 was more expressed in MDM infected with M. tuberculosis as compared with L. pneumophila ( Fig. 1 ) and this observation explained why this clone was scored as positive from the subtracted library, although the difference did not reach significant levels (p = 0.13). The protein expression detected by ELISA in the cellular supernatants was high with very small variations between M. tuberculosis (median = 12.7 ng/ml, Interquartile Range (IR) = 52.4 ng/ml) and L. pneumophila infected MDM (median = 11.3 ng/ml, IR = 53.9 ng/ml, n = 5). Regarding the production of CXCL7 by non-infected cells, given for comparison purposes, values were very similar with a median = 12.6 ng/ml, IR = 53.9 ng/ml. At this point, even though our results did not seem so encouraging in terms of differences, we speculated that such an elevated protein production, at ng/ml concentration levels, should have a biological significance.
Since very little information was available about the role of CXCL7 in infection, we decided to analyze its participation in the response of MDM and PMN to infection by intracellular bacteria.
PMN produce CXCL7
The production of CXCL7 by monocytes has been known for some time (El-Gedaily et al., 2004 ), but we have not found in the literature any reliable description of CXCL7 production in PMN, despite their use in the studies of CXCL7 post-translational modifications. For this reason, it was unexpected to find that PMN from two out of five volunteers expressed the CXCL7 gene. We also studied the protein production, and confirmed that the supernatants from the two PMN that had gene expression and had been infected with M. tuberculosis had a median of 7.8 and 30.9 ng/ml, and infected with L. pneumophila, 10.3 and 32.1 ng/ml, respectively, similar to the amounts in MDM. Supernatants from the other three volunteers did not have CXCL7, indicating that PMN are not constitutively expressing this gene and hence may not be helpful in chemotaxis.
To explore the possibility that polymorphisms in the proximal region of the CXCL7 promoter explained these differences of expression among individuals, we amplified the gene promoter by PCR (Transcriptional Regulatory Element Database, Accession number 32462), using the following primers:
TACACTCGAGGGTACTCTTAGGTGGTAG (F) and TACAAAGCTTGCAGATAAGTGGCTTCTC (R), which include a Xho I and a Hind III restriction sites, respectively. The sequence between these primers ranges from -14 to -670 from the transcription start nucleotide and in all five cases the nucleotide sequence of the promoter was identical to that of the database. We therefore concluded that mechanisms other than the transcriptional regulation in the proximal region of the promoter accounted for the observed differences.
Given the number of CXCL7 variants that has been reported, we studied which form of the protein was present in both MDM and PMN supernatants. To help in the identification of variants we constructed a plasmid expressing PPBP and transfected it into the myeloid leukemia K562 cells. We chose this cell line because they exhibit megakaryocyte markers when differentiated with PMA (Alitalo, 1990 ) and platelets, which store large amounts of NAP-2 , come from megakaryocytes.
Supernatants of the transfected cells were immunoprecipitated and analyzed by Western blot (Fig. 2, lane 3) . The PPBP construct generated three protein products with molecular weights consistent with those of the proteins PPBP (14.0 kD), PBP (10.3 kD) and NAP-2 (7.6 kD). This result demonstrates the capacity of K562 cells to proteolyze higher molecular weight variants, although these cells may not be differentiated to macrophages (Koeffler et al., 1981 ). An additional higher band could be detected, but its molecular weight does not correspond to any of the CXCL7 variants. We ignore the nature of this band, although we suspect it could be an oxidized form of PPBP which have resisted the strong reducing conditions of the electrophoresis. Although this pattern is suggestive, we may not assign a definitive identity to each of the bands unless they are sequenced, because post-translational modifications, even involving a few amino acids, may not be ruled out.
When we analyzed both PMN and MDM supernatants (lanes 1 and 2, respectively), we observe a protein which migrates like the protein of the same molecular weight of PBP recognized in the K562 supernatant. MDM has traces of the higher molecular weight band and, as it would be expected, both MDM and PMN produce a smaller molecular weight variant, most likely NAP-2, but in very small amounts. The same pattern was observed in the supernatant of phagocytes infected with either M. tuberculosis or L. pneumophila (data not shown).
CXCL7 induces limited chemotaxis in PMN
The best characterized biological activity of several of the CXCL proteins is the induction of chemotaxis in PMN. We consequently analyzed the level of chemotaxis induced by the CXCL7 protein present in the supernatant of MDM infected M.
tuberculosis. It was known that M. tuberculosis induces the production of CXCL8 (Zhang et al., 1995) a chemokine that binds to CXCR1 and CXCR2, the same CXCL7 receptors (Moser et al., 1991) . Therefore, a comparison between both chemokines was warranted and we confirmed by ELISA their presence in the supernatants of infected cells, with a median of 8.3 ng/ml for CXCL7 and 102 ng/ml for CXCL8. CXCL8 was also present in the supernatant of non-infected cells (median = 66.9 ng/ml), less than the To investigate the molecules involved in this activity we used an anti-human NAP-2 neutralizing antibody that recognizes all variants of CXCL7 and an anti-human IL-8 neutralizing antibody. Some inhibition of chemotaxis was detected in the presence of the anti-NAP-2 antibody, but this activity was completely abolished in the presence of the anti-IL-8 antibody, with a calculated migration index even below the one observed for the supernatant of non-infected cells (Fig. 3) . These results suggest that CXCL8 is the main chemokine that attracts PMN in this setting. Whatever the actual identity of the CXCL7 variants presents in the supernatant, their induced chemotaxis was small. From this observation it is difficult to conclude that the main biological function of CXCL7 in these cellular models is chemotaxis for PMN, because CXCL8 seems to play this role predominantly. This deduction brought about the question about additional biological roles for CXCL7.
NAP-2 enhances the antimicrobial activity against L. pneumophila induced by IFNγ in MDM
With the aim of investigating possible additional biological roles for CXCL7, we tested whether NAP-2 was able to affect microbial killing, one of the more important activities in phagocytes. M. tuberculosis multiplies in both MDM (Crowle and May, 1981) and PMN (Jones et al., 1990) . Indeed, we observed a significant growth of the bacteria in macrophages, and a slight increase in their number in PMN, although not statistically significant. Nevertheless, we did not detect any influence of either IFNγ or NAP-2 on the growth rate of the bacilli (Fig. 4) . A different situation was, however, observed for L. pneumophila. As expected (Horwitz and Silverstein, 1981) , PMN kill a small proportion of the bacteria after one day of infection, because there is a significant decrease in the number of bacteria recovered as compared with the number in the inoculum. In contrast, no differences were detected when cells were treated with either IFNγ or NAP-2. Regarding MDM, after four days of infection, L. pneumophila multiplied 3 orders of magnitude. NAP-2 itself did not alter this level of multiplication but it seems to cooperate with IFNγ to kill them. When only IFNγ is added, a decrease of viable bacteria is observed, as compared with the inoculum, but it does not reach statistical significance. This result implies a bacteriostatic effect of this cytokine, because it inhibits the intracellular multiplication of L. pneumophila. The antimicrobial activity reaches statistical significance in the presence of both IFNγ and NAP-2, with a further 0.5 log decrease in the number of recovered bacteria (Fig. 4) . This result suggests that although IFNγ is the critical cytokine that controls L. pneumophila infections, other factors, like NAP-2, may synergize with it.
To gain further evidence of the influence of NAP-2 in the antimicrobial activity of macrophages, we stably transfected the monocytic cell line U937 with the NAP-2 construct. Cells were differentiated to macrophages with PMA and infected with L.
pneumophila in the presence of IFNγ (Table 1) . Cells transfected with the pcDNA3 vector (negative control) allowed the multiplication of the bacteria nearly 3 orders of magnitude. IFNγ inhibited this level of multiplication, but differences were not statistically significant. In cells transfected with the NAP-2 construct L. pneumophila growth was, however, significantly inhibited, although IFNγ did not show much activity in these cells. We consequently conclude that NAP-2 also enhances antimicrobial activity in transfected U937 cells. This result does not perfectly mirror the data obtained with primary cells, but we need to consider that the transfected cells constitutively express NAP-2 (not PBP), and that they do not behave exactly like MDM, because in these cells, IFNγ only marginally inhibits the multiplication of L. pneumophila.
U937 cells transfected with a NAP-2 construct have increased adherence to fibronectin
While culturing U937 cells, we noticed that cells transfected with the NAP-2 construct, but not with the empty vector pcDNA3, adhered to the culture vessel surface. This is an additional biological activity that may confer CXCL7 an important role in infection, and had been previously described (Detmers et al., 1991) . We found that U937 cells are an excellent model for the study of this phenomenon. We analyzed the adhesion properties of transfected cells and observed a dramatic enhancement when the substrate was fibronectin, as compared with plastic (culture vessel surface), laminin or collagen type IV. To further characterize this activity we used a fibronectin binding inhibitor, a peptide with the sequence GRGDSP, which includes the fibronectin RGD motif recognized by some integrins (Ruoslahti and Pierschbacher, 1987) . This peptide successfully competed with fibronectin for cell binding (Fig. 5 ).
Discussion
From a subtraction library we have cloned CXCL7 as a candidate gene that may influence the antimicrobial activity of human phagocytes against M. tuberculosis or L.
pneumophila. It was surprising to find out that CXCL7 was constitutively produced in MDM and that the amount of protein in supernatants did not vary after infection regardless of the bacterial species. There is not always a perfect correspondence between gene expression and the amount of the extracellular protein detected. For example, although Lactobacillus casei induces the CXCL10 (IP-10) gene expression, it also inhibits the extracellular secretion of the protein (Hoermannsperger et al., 2009 ).
Conversely, M. tuberculosis increases IP-10 protein production despite inhibition of IP-10 transcription (Bai et al., 2010) . From these data we infer that post-transcriptional regulation seems to play an important role in the production of these proteins.
The first interesting finding that we report is that the PMN of some, but not all, individuals produce CXCL7, which may explain negative results in other studies in which only an isolated individual was examined. To our knowledge, our results constitute the first report in which the nature of CXCL7 variants is characterized in phagocyte supernatants. Although El-Gedaily et al. had detected PBP only in monocyte lysates (El-Gedaily et al., 2004) , we demonstrate the presence of CXCL7 derivatives in the supernatants of both PMN and MDM. The ability of both PMN and monocytes to proteolyze PPBP derivatives to NAP-2 had already been described (El-Gedaily et al., 2004; Walz and Baggiolini, 1990) and therefore, the presence of this band in supernatants was expected. Iida et al. identified a protein that crossreacted with a platelet derived growth factor (PDGF) antibody, and that they termed leukocyte derived growth factor (LDGF). Using this antibody they cloned the corresponding gene and found that it represented what is now regarded as CXCL7. This antibody was able to recognize a protein with a molecular weight close to 16 kD in PMN supernatants.
Instead, in the supernatants of monocytes and T lymphocytes a smaller protein (~ 14 kD) was identified (Iida et al., 1996 El-Gedaily et al., 2004) . Furthermore, granulocytic differentiation of the promyelocytic HL60 cell line with dimethyl sulfoxide did not induce its expression (Skerka et al., 1993) .
We have showed that infection with either M. tuberculosis or L. pneumophila does not increase the production of CXCL7. In contrast, M. tuberculosis has been described to increase the CXCL8 expression and the CXCL8 production (Zhang et al., 1995) , a result that we have confirmed. When analyzing the chemotactic properties of supernatants from non-infected and M. tuberculosis infected cells, the different migration indexes observed were consistent with the amounts of CXCL8, but not of CXCL7. Namely, the chemotaxis induced by supernatants of non-infected cells is lower than the induced by the supernatant of M. tuberculosis infected cells.CXCL7 exhibits two different chemotactic peaks (Ludwig et al., 1997) , so it is possible that the amount of CXCL7 present in the supernatants is not optimal. On the other hand, it is also possible that the particular variants of CXCL7 in the supernatants do not promote chemotaxis. All these reasons may explain that only the neutralization of CXCL8
completely abolishes the chemotaxis of PMN, and that CXCL7 variants may have other little investigated biological roles.
We have found that NAP-2 influences the microbicidal activity of human MDM.
In a recent report, Khajoee et al. show that in granulocyte-macrophage colonystimulating factor (GM-CSF)-induced MDM, CXCL7 inhibits the growth of M.
tuberculosis (Khajoee et al., 2006) . We have not observed such effect, but there are several differences in our experimental conditions. First, we use IFNγ activated MDM,
and not GM-CSF differentiated MDM. Second, their bacterial model is M. tuberculosis
H37Ra, an attenuated strain, whereas we have chosen a virulent clinical isolate. Third, they lyse the infected cells after 6 days, while we do it at 4 days. In their hands, osteopontin, a protein with chemokine properties, also inhibits M. tuberculosis growth.
In contrast, the effect in the antimicrobial activity that we detect is against L.
pneumophila. Although it does not promote any change in their multiplication in MDM, it enhances the bactericidal activity of IFNγ, a cytokine already reported to induce macrophages to inhibit the growth of this bacteria (Bhardwaj et al., 1986) . Tang et al.
have shown that the CXCL7 variants PBP and CTAP-III are also antimicrobial peptides (Tang et al., 2002) . Furthermore, Schaffner et al. have also identified PBP and CTAP-III as monocyte products with antimicrobial activity , which may explain the killing of L. pneumophila that we have observed. Nevertheless, NAP-2 has not been tested in either study. In contrast, Krijgsveld et al. have not detected antimicrobial activity for NAP-2 (Krijgsveld et al., 2000) . We do not believe that the effect that we observe against L. pneumophila depends on the antimicrobial activity of NAP-2 because in the absence of IFNγ it does not exert any apparent activity in either
MDM or PMN. To analyze in different conditions whether NAP-2 may modulate the growth inhibition of the bacteria we used a classical model in L. pneumophila infection, the monocytic cell line U937 (Pearlman et al., 1988) and we have observed that in cells transfected with the NAP-2 construct 3.5-fold less bacteria were recovered as compared with cells transfected with the empty vector, with log CFU from 5.77 to 5.23.
The influence of CXCL chemokines in cellular adhesion has already been reported. Detmers et al. found that the increase of adherence induced was dependent on the integrin CD11b/CD18 (αMβ2) (Detmers et al., 1991) . We have expanded our knowledge about the influence of NAP-2 in the induction of cell adhesion. We found that the adherence of transfected cells was specific, as they adhered to fibronectin, but not to laminin or collagen type IV. Integrins that mediate the binding to fibronectin are different from CD11b/CD18, because they do not use the β2 subunit (CD18).
Fibronectin is present in plasma, basal lamina or cell surfaces and fibronectin peptides inhibit leukocyte integrin binding and block recruitment to limit inflammation (Wahl et al., 1996) , which supports that it is involved in the immune response. Moreover, binding of monocytes to fibronectin enhances IFNγ-induced signalling events (McCarthy et al., 1997) . We find intriguing the possibility that there may be a relationship between the adherence promoted by NAP-2 and the observed enhancement of the antimicrobial activity induced by IFNγ.
In conclusion, our data indicates that CXCL7 play important roles additional to chemotaxis that may help phagocytes fighting intracellular bacteria. These roles include the enhancement of IFNγ induction of antimicrobial activity and cellular adhesion.
Susceptibility to tuberculosis and legionellosis has a very complex nature and we need to increase our knowledge of the different factors that influence the final outcome of these diseases. Pairwise comparisons versus "Inoculum" with *P < 0.05 were considered significant. N.S. stands for Non-Significant. Data are the average of the log number of colonies with SD (95% confidence interval) from four independent experiments. Pairwise comparisons versus the pcDNA3 group with *P < 0.05 were considered significant. 
